Literature DB >> 8086446

Only cytidines 5' of the apolipoprotein B mRNA mooring sequence are edited.

J W Backus1, D Schock, H C Smith.   

Abstract

A 22 nucleotide 'cassette' containing three distinct sequence elements is required for efficient apolipoprotein B (apoB) RNA editing. One of the elements, the mooring sequence, has been proposed as the apoB RNA-recognition element in binding 66 and 44 kDa proteins during editosome assembly. We show here that editing can only take place on cytidines 5' of the mooring sequence; thereby providing further proof for the proposed orientation-specific assembly of editing factors at the editing site. We also provide direct evidence for the existence of a cryptic mooring sequence immediately downstream of the wild-type editing site (between nucleotides 6688-6710). When a cytidine is introduced 5' of this site (at nucleotide 6687), editing occurs at wild-type (nucleotide 6666) and cryptic sites. The cytidine to be edited is not involved in 66 and 44 kDa protein binding, and therefore, the data suggest that the cryptic mooring sequence binds these factors, and may facilitate factor recruitment to the wild-type editing site. These data may also explain why wild-type levels of editing on chimeric, RNA editing substrates can only be achieved when the 22 nucleotide editing cassette is flanked 3' by apoB RNA sequence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086446     DOI: 10.1016/0167-4781(94)90240-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

2.  Toward the therapeutic editing of mutated RNA sequences.

Authors:  T M Woolf; J M Chase; D T Stinchcomb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

3.  An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.

Authors:  S Anant; N O Davidson
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing.

Authors:  Y Yang; Y Yang; H C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.

Authors:  Debnath Mukhopadhyay; Shrikant Anant; Robert M Lee; Susan Kennedy; David Viskochil; Nicholas O Davidson
Journal:  Am J Hum Genet       Date:  2001-11-27       Impact factor: 11.025

6.  Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.

Authors:  G S Dance; P Beemiller; Y Yang; D V Mater; I S Mian; H C Smith
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

7.  Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.

Authors:  M P Sowden; M J Eagleton; H C Smith
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

8.  An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B RNA editing.

Authors:  D Schock; S R Kuo; M F Steinburg; M Bolognino; J D Sparks; C E Sparks; H C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

9.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.

Authors:  S Yamanaka; M E Balestra; L D Ferrell; J Fan; K S Arnold; S Taylor; J M Taylor; T L Innerarity
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.

Authors:  G R Skuse; A J Cappione; M Sowden; L J Metheny; H C Smith
Journal:  Nucleic Acids Res       Date:  1996-02-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.